Sanofi subsidiary Genzyme is tying up with gene therapy upstart Voyager Therapeutics, gambling $100 million upfront on the hot field and promising up to $745 million in milestones for their partnership on a full slate of development programs.

…read more

Source: Sanofi embarks on an $845M gene therapy R&D odyssey with Voyager


0 No comments